Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Support Care Cancer ; 29(12): 7323-7328, 2021 Dec.
Article in English | MEDLINE | ID: mdl-34041616

ABSTRACT

PURPOSE: Chemotherapy education provided by nurses to patients is a fundamental component of high-quality cancer care. The Quality Oncology Practice Initiative (QOPI ®) provides guidance on treatment-related aspects of chemotherapy education (diagnosis, goals, regimen, schedule, adverse events, follow-up), but recommendations on practical lifestyle issues lack evidence and standardization. METHODS: An anonymous, voluntary, uncompensated survey was distributed in October 2019 to 12,995 oncology certified nurses who report working in adult outpatient clinic/infusion room settings. An electronic survey was designed to determine current practice in nurse-patient counseling related to lifestyle and behavior during chemotherapy treatment. RESULTS: Survey responses were obtained from 1243 oncology certified nurses (9.6%). Nurses reported that their education practice was influenced by their institution and coworkers (other nurses or oncologists). Most nurses (> 50%) reported counseling on all topics asked. Most frequently counseled topics included water intake, infection monitoring, alcohol consumption, exercise, and mucositis. Less frequently counseled topics included hair dye, laundry practices, and mask wearing (pre-pandemic). CONCLUSION: This study highlighted that chemotherapy nurses routinely counsel patients on important topics that lack evidence-based recommendations. In the absence of evidence, nurses rely on learned education practices, most commonly institutional guides or recommendations adopted from other nurses or oncologists. On important topics that lack evidence, expert panel review and development of consensus guidelines could standardize and improve the education process for both oncology nurses and patients.


Subject(s)
Neoplasms , Nurse Clinicians , Adult , Counseling , Exercise , Humans , Neoplasms/drug therapy , Surveys and Questionnaires
2.
Ophthalmology ; 120(4): 766-72, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23290981

ABSTRACT

PURPOSE: To determine clinical features predictive of growth of iris nevus into melanoma. DESIGN: Retrospective, comparative case series. PARTICIPANTS: A total of 1611 consecutive patients referred to an ocular oncology center with iris nevus. INTERVENTION: Observation and photographic documentation. MAIN OUTCOME MEASURES: Growth into melanoma. RESULTS: The mean age at referral for iris nevus was 51 years (median, 54; range, <1-94 years). At presentation, the mean tumor basal diameter was 3 mm (median, 3 mm; range, <1-12 mm) and mean tumor thickness was 0.8 mm (median, 0.5 mm; range, 0-5 mm). All patients were initially diagnosed with benign iris nevus. Growth of iris nevus to melanoma was confirmed in 2% of eyes (n = 27) over a mean follow-up of 68 months (median, 46 months; range, 3-465 months). By Kaplan-Meier estimates, iris nevus growth to melanoma occurred in <1%, 3%, 4%, 8%, and 11% at 1, 5, 10, 15, and 20 years, respectively. Factors predictive of iris nevus growth to melanoma by multivariable analysis included age ≤ 40 years at presentation (hazard ratio [HR], 3), episode of hyphema (HR, 9), 4:00 to 9:00 clock hour location of tumor (HR, 9), diffuse tumor (involving entire iris surface) (HR, 14), ectropion uveae (HR, 4), and feathery tumor margins (HR, 3). Additional important factors by univariable analysis included tumor seeding on the iris or in the anterior chamber angle, feeder vessels, and nodule formation. These factors can be remembered using the mnemonic ABCDEF, representing A = age young, B = blood, C = clock hour inferior, D = diffuse, E = ectropion, and F = feathery margin. CONCLUSIONS: In an analysis of 1611 cases of iris nevus referred for evaluation at an ocular oncology center, growth into melanoma occurred in 8% by 15 years. Risk factors for growth, identified by ABCDEF included Age young, Blood (hyphema), Clock hour inferior, Diffuse configuration, Ectropion uveae, and Feathery tumor margin.


Subject(s)
Anterior Chamber/pathology , Cell Transformation, Neoplastic/pathology , Iris Neoplasms/pathology , Melanoma/pathology , Nevus, Pigmented/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Disease Progression , Female , Follow-Up Studies , Humans , Infant , Iris , Male , Middle Aged , Retrospective Studies , Risk Factors , Young Adult
3.
J Med Case Rep ; 11(1): 325, 2017 Nov 18.
Article in English | MEDLINE | ID: mdl-29149910

ABSTRACT

BACKGROUND: Iron deficiency anemia is a common finding in women of child-bearing age. Pica, or the ingestion of non-food or non-nutritive items, is a well-known manifestation of iron deficiency. A high sodium diet increases risk for nephrolithiasis. We describe the case of a 31-year-old woman with recurrent calcium nephrolithiasis and anemia who ate ice chips as well as spoons of salt daily. Treatment of pica may prove effective in preventing recurrent nephrolithiasis. CASE PRESENTATION: A 31-year-old white woman with a past medical history of menorrhagia, anemia, and recurrent calcium nephrolithiasis presented for preoperative evaluation prior to ureterolithotomy. She described a daily pattern of eating continually from a cup of ice chips accompanied by multiple spoons of salt directly out of a salt shaker. These cravings had been present for many years, were bothersome to her, and interfered with her daily life. Laboratory findings revealed hemoglobin of 10.9 g/dL with ferritin of 3 ng/mL. History, physical, and laboratory data were consistent with pica secondary to iron deficiency anemia. She was prescribed orally administered ferrous sulfate 325 mg three times a day with meals. She continues to struggle with the symptoms of pica and orally administered supplementation. CONCLUSIONS: It is important that clinicians consider the possible diagnosis of sodium chloride pica in patients with iron deficiency anemia and recurrent nephrolithiasis. Treatment of anemia and resolution of pica may prove effective in preventing future nephrolithiasis. Specific questioning about pica symptoms in patients with iron deficiency anemia and recurrent nephrolithiasis may be helpful diagnostically and therapeutically.


Subject(s)
Anemia, Iron-Deficiency/complications , Nephrolithiasis/etiology , Pica/etiology , Sodium Chloride, Dietary/adverse effects , Adult , Anemia, Iron-Deficiency/drug therapy , Diagnosis, Differential , Female , Ferritins/blood , Ferrous Compounds/administration & dosage , Humans , Pica/diagnosis , Recurrence
SELECTION OF CITATIONS
SEARCH DETAIL